IPO registrations (S-1, F-1) · Registrants
MANNKIND CORP
- SEC CIK
- 899460 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2004-04-30, last 2017-07-03; 2 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2004-07-28; declared effective 2006-11-07
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1 CASPER STREET, Danbury, CT 06810
- EIN
- 13-3607736
- Ticker
- MNKD (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- MANNKIND CORP on the corporate pages
Offering terms
- Proposed price range
- $13.00–$15.00 per share (S-1/A filed 2004-07-27)
- Final price
- $10.18 per share, below the range (424B4 filed 2004-07-28, an initial public offering)
- Shares sold
- 6,250,000
- Gross proceeds
- $63,625,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MNKD
- Lead underwriters
- UBS; Piper Sandler (1,250,000 shares); Wachovia (729,166 shares); Jefferies (729,166 shares); Harris Nesbitt (729,166 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: MANNKIND CORPORATION EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: MannKind Corporation Fuzzy (name and state)
- Business registration: MANNKIND CORPORATION Fuzzy (name and state)
- Business registration: MANNKIND CORPORATION Fuzzy (name and state)
- Form 5500 plan sponsor: MANNKIND CORPORATION EXACT (EIN (EXACT))
- Lobbying client: MANNKIND CORPORATION Fuzzy (name and state)
- SEC filer: MANNKIND CORP EXACT (CIK (EXACT))
- Person page: Alfred E Mann Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,OfficerOther))
- Person page: Anthony C Hooper Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 16
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2004-04-30 | S-1 | S-1 (registration) | MANNKIND CORP | 0000950148-04-000827 ↗ |
| 2004-06-10 | S-1/A | S-1/A (amendment) | MANNKIND CORP | 0000950148-04-000965 ↗ |
| 2004-07-06 | S-1/A | S-1/A (amendment) | MANNKIND CORP | 0000950148-04-000972 ↗ |
| 2004-07-26 | S-1/A | S-1/A (amendment) | MANNKIND CORP | 0000950129-04-005113 ↗ |
| 2004-07-27 | S-1/A | S-1/A (amendment) | MANNKIND CORP | 0000950129-04-005169 ↗ |
| 2004-07-27 | S-1/A | S-1/A (amendment) | MANNKIND CORP | 0000950148-04-000982 ↗ |
| 2004-07-28 | S-1MEF | S-1MEF (added securities) | MANNKIND CORP | 0000950134-04-010689 ↗ |
| 2004-07-28 | 424B4 | 424B4 (final prospectus) | MANNKIND CORP | 0000950148-04-000984 ↗ |
| 2006-11-07 | EFFECT | EFFECT (declared effective) | MANNKIND CORP | 9999999995-06-002215 ↗ |
| 2007-08-15 | EFFECT | EFFECT (declared effective) | MANNKIND CORP | 9999999995-07-003326 ↗ |
| 2010-05-11 | EFFECT | EFFECT (declared effective) | MANNKIND CORP | 9999999995-10-001461 ↗ |
| 2012-09-24 | EFFECT | EFFECT (declared effective) | MANNKIND CORP | 9999999995-12-002804 ↗ |
| 2016-04-27 | EFFECT | EFFECT (declared effective) | MANNKIND CORP | 9999999995-16-004350 ↗ |
| 2017-07-03 | S-1 | S-1 (registration) | MANNKIND CORP | 0001193125-17-220382 ↗ |
| 2017-07-14 | EFFECT | EFFECT (declared effective) | MANNKIND CORP | 9999999995-17-001827 ↗ |
| 2019-04-05 | EFFECT | EFFECT (declared effective) | MANNKIND CORP | 9999999995-19-000628 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2004-07-27 | S-1/A | registration statement | $13.00–$15.00 | 5,500,000 | - | Nasdaq MNKD | 6 | primary document; range, shares headline, underwriting table 1, cover names 5 | document ↗ | |
| 2004-07-28 | 424B4 | final prospectus | $10.18 | 6,250,000 | $63,625,000 | Nasdaq MNKD | 5 | primary document; price line, shares headline, proceeds computed, underwriting table 4, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Thomson David | Officer | Corp VP & General Counsel; EVP Genl Counsel & Secretary; VP & General Counsel | 120 | 2006–2026 | |
| ANDERSON RICHARD L | Officer | Corporate VP; VP & CFO | 12 | 2006–2008 | |
| Cheatham W Wendell | Officer | VP, Chief Medical Officer | 1 | 2006 | |
| Edstrom Hakan | Director,Officer | President & CEO; President & COO | 55 | 2006–2015 | |
| MANN ALFRED E | Director,OfficerOther; OfficerOther | Chairman & CEO; Executive Chairman | 37 | 2006–2015 | person page Fuzzy |
| Burns Dan | Officer | VP & President, MKBP | 2 | 2006 | |
| Martens Juergen | Officer | Corporate VP; Corporate VP and COO | 67 | 2006–2015 | |
| Palumbo Diane | Officer | Vice President, Human Resource | 62 | 2006–2015 | |
| Connell Kathleen | Director | 1 | 2006 | ||
| Consiglio Ronald J | Director | 26 | 2006–2026 | ||
| Friedman Michael A | Director | 22 | 2006–2026 | ||
| Keltner Llew | Director | 1 | 2006 | ||
| KRESA KENT | Director | 25 | 2006–2024 | ||
| MacCallum David | Director | 16 | 2006–2018 | ||
| NORDHOFF HENRY L | Director | 16 | 2006–2019 | ||
| Richardson Peter C | Officer | Chief Scientific Officer | 18 | 2006–2012 | |
| Murren Heather Hay | Director | 4 | 2007–2008 | ||
| COHEN ABRAHAM E | Director | 14 | 2007–2012 | ||
| Riesenberger John R. | Officer | VP & Chief Commercial Officer | 4 | 2008 | |
| PFEFFER MATTHEW J | Director; Officer | CEO, CFO, Director; Corporate VP and CFO | 41 | 2008–2017 | |
| Shannon James Samuel | Director | 20 | 2010–2026 | ||
| Adreveno Linda A | Officer; Other | Sr. VP, HR | 2 | 2015–2016 | |
| Kocinsky Joseph | Officer | Chief Technology Officer; Corp VP, CTO; CTO | 18 | 2015–2022 | |
| Urbanski Raymond W. | Officer | CMO; Corp VP, CMO | 3 | 2015–2017 | |
| Alinaya Rosabel Realica | Officer | SVP, Investor Relations; SVP, Prin Acctg Officer; VP, IR & Treasury | 15 | 2016–2020 | |
| Castagna Michael | Director,Officer; Officer | Chief Commercial Officer; Chief Executive Officer | 77 | 2016–2026 | |
| Tross Stuart A | Officer | Chief People & Workpl Officer; Corp VP, Chief People Officer; EVP, Chief People Officer | 58 | 2017–2026 | |
| Alfred E. Mann Living Trust | TenPercentOwner | 2 | 2017–2018 | ||
| Mann Group, LLC | TenPercentOwner | 2 | 2017–2018 | ||
| Binder Steven B. | Director; Officer | Chief Financial Officer; EVP Special Projects | 48 | 2017–2026 | |
| McCauley Patrick | Officer | Chief Commercial Officer | 13 | 2017–2020 | |
| Barton Courtney | Officer | Chief Compliance Officer; Chief Compl & Privacy Officer | 9 | 2017–2019 | |
| Kendall David M | Officer | Chief Medical Officer | 12 | 2018–2020 | |
| Ingram Elizabeth Garrett | Officer | Chief Marketing Officer | 6 | 2018–2019 | |
| MUNDKUR CHRISTINE | Director | 11 | 2019–2026 | ||
| HOOPER ANTHONY C | Director | 12 | 2020–2026 | person page Fuzzy | |
| Grancio Jennifer | Director | 10 | 2020–2026 | ||
| Galindo Alejandro | Officer | Chief Commercial Officer; EVP Endocrine Business Unit | 18 | 2020–2022 | |
| Kay Sabrina | Director | 9 | 2020–2026 | ||
| Singh Sanjay R | Officer | EVP Technical Operations | 13 | 2022–2026 | |
| Sabella Lauren M | Officer | EVP Chief Operating Officer; EVP Operations | 10 | 2023–2025 | |
| BLANK BURKHARD | Officer | EVP Chief Medical Officer | 8 | 2023–2025 | |
| Prentiss Christopher B | Officer | Chief Financial Officer | 9 | 2024–2026 | |
| Marasco Dominic | Officer | Pres, Endocrine Business Unit | 6 | 2025–2026 | |
| Ahuja Ajay | Officer | Chief Medical Officer | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | MannKind Corporation | CT | State business registries | name and state |
| Business registration | MANNKIND CORPORATION | CT | State business registries | name and state |
| Business registration | MANNKIND CORPORATION | CT | State business registries | name and state |
| Business registration | MANNKIND CORPORATION | CT | State business registries | name and state |
| Lobbying client | MANNKIND CORPORATION | CT | Federal lobbying (LDA) | name and state |
| SEC filer | MANNKIND CORP | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | MannKind Corporation | CT | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | MANNKIND CORPORATION | EIN (EXACT) | ||
| Person page | Alfred E Mann | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,OfficerOther) | |
| Person page | Anthony C Hooper | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CT first:
- CHIREX INC CT
- ACHILLION PHARMACEUTICALS INC CT
- Rib-X Pharmaceuticals, Inc. CT
- Oracle Healthcare Acquisition Corp. CT
- NANOVIRICIDES, INC. CT
- KOLLTAN PHARMACEUTICALS INC CT
- Trevi Therapeutics, Inc. CT
- Yarrow Bioscience, Inc. CT
- Loxo Oncology, Inc. CT
- ARVINAS, INC. CT
In other datasets, the same topic (Health) in CT:
- Nonprofit: AIDS BUDDY NETWORK (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health